Search clinical trials for: Histone Deacytelase Inhibitors
Total 64440 results
-
Dana-Farber Cancer InstituteCelgene; Secura Bio, Inc.TerminatedPediatric Cancer | Diffuse Intrinsic Pontine Glioma | Pediatric Brain Tumor | Diffuse Glioma | Pediatric Brainstem Glioma | Pediatric Brainstem Gliosarcoma, RecurrentUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteMerck Sharp & Dohme LLCActive, not recruitingLung Cancer | Non-small Cell Lung CancerUnited States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States, Puerto Rico
-
University of MelbourneMerck Sharp & Dohme LLC; The AlfredTerminated
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Acute Erythroid Leukemia | Acute Megakaryoblastic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Refractory Anemia | Myelodysplastic Syndrome With Ring SideroblastsUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingBladder CancerUnited States
-
UNICANCERMerck Sharp & Dohme LLC; Fondation ARC; ERA-NETActive, not recruitingVulvar Cancer | Cervix Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Penile Cancer | Squamous Cell Lung CancerFrance
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Classic Hodgkin Lymphoma | Refractory... and other conditionsUnited States
-
Xynomic Pharmaceuticals, Inc.Active, not recruitingFollicular LymphomaSpain, United States, France
-
Xynomic Pharmaceuticals, Inc.Cancer Institute and Hospital, Chinese Academy of Medical SciencesActive, not recruitingNon Hodgkin LymphomaChina
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Syndax PharmaceuticalsActive, not recruitingLymphoma | Refractory | RelapsedUnited States
-
St. Jude Children's Research HospitalBaylor College of Medicine; Gateway for Cancer ResearchActive, not recruitingAcute Lymphoblastic LeukemiaUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Aggressive Non-Hodgkin Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
ItalfarmacoCompletedDuchenne and Becker Muscular Dystrophy | Polycytemia VeraCanada
-
UNC Lineberger Comprehensive Cancer CenterSyndax PharmaceuticalsCompletedMelanomaUnited States
-
Syndax PharmaceuticalsPfizer; Merck KGaA, Darmstadt, GermanyCompletedStudy of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI); Syndax PharmaceuticalsCompletedPancreatic Cancer | Cholangiocarcinoma | Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer | Metastatic Cholangiocarcinoma | Unresectable CholangiocarcinomaUnited States
-
The University of Texas Health Science Center at...CompletedColorectal CancerUnited States
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Nabil AdraCompletedRenal Cell Carcinoma | Urinary Bladder NeoplasmsUnited States
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
Vastra Gotaland RegionMerck Sharp & Dohme LLC; Syndax PharmaceuticalsCompletedMetastatic Uveal MelanomaSweden
-
CelgeneCompletedLymphoma, T-Cell, PeripheralJapan
-
Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.CompletedPeripheral Nervous System DiseasesChina
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Grade 3 Follicular Lymphoma | Plasmablastic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Primary Effusion Lymphoma | AIDS-Related Primary Effusion Lymphoma | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor... and other conditionsUnited States
-
Abramson Cancer Center at Penn MedicineCompletedColorectal CancerUnited States
-
ItalfarmacoCompletedDuchenne Muscular Dystrophy (DMD)Italy
-
University of WashingtonNational Cancer Institute (NCI)CompletedHead and Neck Squamous Cell Carcinoma | Recurrent Nasopharynx Carcinoma | Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma | Recurrent Salivary Gland Carcinoma | Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary | Stage IV Nasopharyngeal Carcinoma | Stage IVA... and other conditionsUnited States
-
John MascarenhasCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Celgene Corporation; University... and other collaboratorsCompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Imperial College LondonMedical Research Council; University of Oxford; Guy's and St Thomas' NHS Foundation... and other collaboratorsCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Refractory Mature T-Cell and NK-Cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Brain Stem Neoplasm | Pineal Region Neoplasm | Recurrent Visual Pathway Glioma | Refractory Visual Pathway GliomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, France, Spain, Germany, Greece
-
National Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Extensive Stage Lung Small Cell Carcinoma | Metastatic Malignant Neoplasm in the BrainUnited States
-
New Approaches to Neuroblastoma Therapy ConsortiumUnited TherapeuticsActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Non-Secretory Plasma Cell Myeloma | PlasmacytosisUnited States
-
Regenacy Pharmaceuticals LLCCompletedPainful Diabetic Peripheral NeuropathyUnited States
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCCompletedMelanoma | Non-Small Cell Lung Cancer | Mismatch Repair-Proficient Colorectal CancerUnited States
-
Syndax PharmaceuticalsRoche Pharma AGCompletedBreast CancerUnited States, Georgia
-
Mayo ClinicNational Cancer Institute (NCI)SuspendedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Breast Carcinoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage IV Breast Cancer AJCC v6 and v7 | Breast Adenocarcinoma and other conditionsUnited States
-
Roberto PiliSyndax Pharmaceuticals; Clinigen, Inc.; Indiana University Melvin and Bren Simon...Active, not recruiting
-
University of California, San FranciscoMerck Sharp & Dohme LLCTerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8United States
-
Children's Hospital Medical Center, CincinnatiNo longer availableNeuroblastoma | Pheochromocytoma | ParagangliomaUnited States
-
NCIC Clinical Trials GroupS*BIOCompleted
-
NCIC Clinical Trials GroupS*BIOCompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Mirati Therapeutics Inc.; Astex Pharmaceuticals, Inc.; Stand Up To Cancer and other collaboratorsActive, not recruiting
-
ItalfarmacoTerminatedEffect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease (CD)Crohn's DiseaseBelgium, Italy, Netherlands